Results 31 to 40 of about 61 (47)

Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine.

Am J Physiol Gastrointest Liver Physiol, 2009
Bozarov A, Wang YZ, Yu JG, Wunderlich J, Hassanain HH, Alhaj M, Cooke HJ, Grants I, Ren T, Christofi FL.   +9 more
europepmc   +1 more source

Purinergic receptors and gastrointestinal secretomotor function. [PDF]

Purinergic Signal, 2008
Christofi FL.
europepmc   +1 more source

The identification of inhibitors of Schistosoma mansoni miracidial transformation by incorporating a medium-throughput small-molecule screen. [PDF]

Exp Parasitol, 2010
Taft AS, Norante FA, Yoshino TP.
europepmc   +1 more source

The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor. [PDF]

Front Pharmacol
Ovari I, Viczjan G, Erdei T, Takacs B, Tarjanyi V, Zsuga J, Szucs M, Szilvassy Z, Juhasz B, Gesztelyi R.   +9 more
europepmc   +1 more source

An Affinity-Based Probe for the Human Adenosine A_2A Receptor. [PDF]

J Med Chem, 2018
Yang X, Michiels TJM, de Jong C, Soethoudt M, Dekker N, Gordon E, van der Stelt M, Heitman LH, van der Es D, IJzerman AP.   +9 more
europepmc   +1 more source

Design and pharmacological characterization of VUF14480, a covalent partial agonist that interacts with cysteine 98(3.36) of the human histamine H₄ receptor. [PDF]

Br J Pharmacol, 2013
Nijmeijer S, Engelhardt H, Schultes S, van de Stolpe AC, Lusink V, de Graaf C, Wijtmans M, Haaksma EE, de Esch IJ, Stachurski K, Vischer HF, Leurs R.   +11 more
europepmc   +1 more source

A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig. [PDF]

Br J Pharmacol, 1999
Snowdy S, Liang HX, Blackburn B, Lum R, Nelson M, Wang L, Pfister J, Sharma BP, Wolff A, Belardinelli L.   +9 more
europepmc   +1 more source

Adenosine receptors and asthma. [PDF]

Handb Exp Pharmacol, 2009
Wilson CN, Nadeem A, Spina D, Brown R, Page CP, Mustafa SJ.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The surmountable effect of FSCPX, an irreversible A1 adenosine receptor antagonist, on the negative inotropic action of A1 adenosine receptor full agonists in isolated guinea pig left atria

Archives of Pharmacal Research, 2013
A1 adenosine receptors (A1 receptors) are widely expressed in mammalian tissues; therefore attaining proper tissue selectivity is a cornerstone of drug development. The fact that partial agonists chiefly act on tissues with great receptor reserve can be exploited to achieve an appropriate degree of tissue selectivity.
Rudolf Gesztelyi, Judit Zsuga, Mariann Bombicz   +2 more
exaly   +3 more sources

A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A1 Adenosine Receptor Antagonist So Far

International Journal of Molecular Sciences, 2021
Rudolf Gesztelyi, Bela Juhasz, Judit Zsuga   +2 more
exaly